CSIMarket
 


Kempharm, Inc  (KMPH)
Other Ticker:  
 

Kempharm Inc's Working Capital Ratio

KMPH's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




KMPH Working Capital Ratio (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Change -54.76 % -43.19 % -14.93 % 9.86 % 4.3 %
Y / Y Current Assets Change -72.03 % -48.11 % -72.05 % -60.82 % -49.53 %
Working Capital Ratio MRQ 1.22 0.83 0.58 1.01 1.98
Overall Ranking # # # # #
Seq. Current Liabilities Change -47.82 % -30.49 % -1.3 % 26.39 % -34.49 %
Seq. Current Assets Change -23.61 % 0.51 % -43.57 % -35.45 % 41.73 %



Working Capital Ratio forth quarter 2019 Comment
Current Liabilities decreased faster than Kempharm Inc's Current Assets, this led to improvement in Kempharm Inc's Working Capital Ratio to 1.22, Working Capital Ratio remained below Kempharm, Inc average.

Within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Working Capital Ratio than Kempharm Inc in forth quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is KMPH most successful ?
Working Capital Ratio KMPH on the trailing twelve month basis
Working Capital Ratio forth quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 227
Overall Market # 1368


Working Capital Ratio Statistics
High Average Low
19.06 6.42 0.58
(Mar 31 2016)   (Jun 30 2019)




Financial Statements
Kempharm Inc's Current Liabilities $ 5 Millions Visit KMPH's Balance sheet
Kempharm Inc's Current Assets $ 7 Millions Visit KMPH's Balance sheet
Source of KMPH's Sales Visit KMPH's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingDec 31 2019, within Major Pharmaceutical Preparations Industry Working Capital RatioDec 31 2019 MRQ Current AssetsDec 31 2019 MRQ Current Liabilities
Xenon Pharmaceuticals Inc   3.34 $ 144.866  Millions$ 43.379  Millions
Evoke Pharma Inc  3.33 $ 6.246  Millions$ 1.877  Millions
Checkpoint Therapeutics Inc   3.32 $ 26.966  Millions$ 8.119  Millions
Ptc Therapeutics inc   3.30 $ 779.284  Millions$ 235.857  Millions
Aimmune Therapeutics Inc   3.30 $ 149.077  Millions$ 45.191  Millions
Contrafect Corp  3.26 $ 30.760  Millions$ 9.426  Millions
Eyegate Pharmaceuticals Inc  3.25 $ 4.324  Millions$ 1.331  Millions
Esperion Therapeutics inc   3.20 $ 211.714  Millions$ 66.080  Millions
Synthetic Biologics, Inc.  3.11 $ 16.426  Millions$ 5.275  Millions
Ani Pharmaceuticals Inc  3.04 $ 187.695  Millions$ 61.676  Millions
Theravance Biopharma inc   3.03 $ 338.488  Millions$ 111.703  Millions
Phibro Animal Health Corp  3.03 $ 445.487  Millions$ 147.059  Millions
Zogenix Inc   3.01 $ 287.239  Millions$ 95.389  Millions
Obseva Sa  3.00 $ 74.773  Millions$ 24.917  Millions
Harrow Health Inc   2.99 $ 36.767  Millions$ 12.284  Millions
Progenics Pharmaceuticals Inc  2.97 $ 63.732  Millions$ 21.469  Millions
Chemocentryx Inc   2.95 $ 174.362  Millions$ 59.080  Millions
Perrigo Company Plc  2.93 $ 2,756.900  Millions$ 941.400  Millions
Onconova Therapeutics Inc   2.91 $ 23.474  Millions$ 8.066  Millions
Plx Pharma Inc   2.90 $ 14.283  Millions$ 4.927  Millions
Athersys Inc  2.90 $ 37.171  Millions$ 12.837  Millions
Verastem Inc   2.88 $ 84.961  Millions$ 29.470  Millions
Amphastar Pharmaceuticals Inc   2.84 $ 255.241  Millions$ 90.009  Millions
Hutchison China Meditech Limited  2.80 $ 317.022  Millions$ 113.101  Millions
Alimera Sciences Inc  2.78 $ 32.745  Millions$ 11.793  Millions
Clovis Oncology inc   2.75 $ 366.468  Millions$ 133.084  Millions
Tonix Pharmaceuticals Holding Corp   2.72 $ 13.948  Millions$ 5.135  Millions
Tetraphase Pharmaceuticals Inc  2.71 $ 26.493  Millions$ 9.770  Millions
Immunogen inc   2.70 $ 208.898  Millions$ 77.410  Millions
Zoetis Inc   2.63 $ 4,748.000  Millions$ 1,806.000  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OMN's Profile

Stock Price

OMN's Financials

Business Description

Fundamentals

Charts & Quotes

OMN's News

Suppliers

OMN's Competitors

Customers & Markets

Economic Indicators

OMN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071